SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Feb 01, 2021	View HTML 0001193125-21-024726.pdf 0001193125-21-024726.rtf
8-K	Report of unscheduled material events or corporate event	Jan 28, 2021	View HTML 0001564590-21-002750.pdf 0001564590-21-002750.rtf 0001564590-21-002750.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EFFECT	EFFECT	Jan 25, 2021	View HTML 9999999995-21-000271.pdf 9999999995-21-000271.rtf 9999999995-21-000271.xls
SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Jan 22, 2021	View HTML 0000905148-21-000072.pdf 0000905148-21-000072.rtf 0000905148-21-000072.xls
CORRESP	CORRESP	Jan 21, 2021	View HTML 0001193125-21-013478.pdf 0001193125-21-013478.rtf 0001193125-21-013478.xls
UPLOAD	UPLOAD	Jan 21, 2021	View HTML 0000000000-21-000740.pdf 0000000000-21-000740.rtf
S-3	Simplified registration form	Jan 15, 2021	View HTML 0001193125-21-010201.pdf 0001193125-21-010201.rtf 0001193125-21-010201.xls
3	Initial filing by director officer or owner of more than ten percent.	Jan 14, 2021	View HTML 0000905148-21-000054.pdf 0000905148-21-000054.rtf 0000905148-21-000054.xls
3	Initial filing by director officer or owner of more than ten percent.	Jan 13, 2021	View HTML 0001123292-21-000075.pdf 0001123292-21-000075.rtf 0001123292-21-000075.xls
8-K	Report of unscheduled material events or corporate event	Jan 11, 2021	View HTML 0001564590-21-000851.pdf 0001564590-21-000851.rtf 0001564590-21-000851.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.